Skip to main content

Table 3 The overall response rate and median survival between limited stage PD-L1 positive and negative groups

From: Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience

 

Limited stage disease

P value

PD-L1 positive

PD-L1 negative

(n = 6)

(n = 5)

Male sex (%)

4 (66%)

2 (40%)

 

Received treatment

6 (100%)

5 (100%)

 

Response rates to treatment

6 (100%)

5 (100%)

 

Alive at 1 year

6 (100%)

4 (80%)

 

Median overall survival (mo.)

53

15

0.80